Malaysiakini
NEWS

Phamaniaga all set to manufacture Sinovac Covid-19 vaccine

Bernama

Published

Phamaniaga Bhd has the capacity to manufacture two million doses of Covid-19 vaccine developed by China’s Sinovac Life Sciences Co Ltd per month beginning March this year.

Group managing director Zulkarnain Md Eusope said the vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga's wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd, in Puchong.

He said the group would invest RM3 million to retrofit the plant...

All Access Plan
starting from

~RM12

per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In